Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-27 Sale |
2025-01-31 09:14 am |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
53,590 | $56.25 | $3,014,216 | 148,433 (Direct) |
View |
| 2025-01-27 Sale |
2025-01-31 09:14 am |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
49,074 | $55.72 | $2,734,212 | 149,069 (Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 8:43 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
31,250 | $55.77 | $1,742,958 | 356,424 (Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 8:43 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
5,000 | $57.03 | $285,150 | 112,674 (Direct) |
View |
| 2025-01-27 Sale |
2025-01-29 8:43 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
30,000 | $54.9 | $1,646,978 | 716,062 (Direct) |
View |
| 2025-01-02 Sale |
2025-01-06 2:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.03 | $280,330 | 278,083 (Indirect Direct) |
View |
| 2024-12-16 Sale |
2024-12-18 9:03 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
1,000 | $29.13 | $29,130 | 86,358 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-18 9:01 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,074 | $29.11 | $264,117 | 189,348 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-18 8:52 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
3,800 | $31.1 | $118,172 | 393,292 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:44 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
4,818 | $30.91 | $148,934 | 317,092 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:38 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
2,503 | $30.79 | $77,067 | 263,783 (Indirect Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:29 pm |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
925 | $30.79 | $28,481 | 17,858 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:28 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
2,810 | $30.79 | $86,520 | 71,348 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:26 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
2,817 | $30.79 | $86,735 | 38,335 (Direct) |
View |
| 2024-12-10 Sale |
2024-12-12 8:24 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
7,855 | $30.79 | $241,855 | 597,562 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 7:36 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $32.09 | $802,250 | 716,446 (Direct) |
View |
| 2024-12-02 Sale |
2024-12-04 7:34 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $32.13 | $321,310 | 266,286 (Indirect Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 9:57 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,061 | $27.73 | $251,274 | 127,579 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 5:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $35.19 | $351,890 | 91,007 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 09:04 am |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
50,716 | $31.57 | $1,601,252 | 276,286 (Indirect Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 09:00 am |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
108,366 | $31.73 | $3,438,312 | 904,561 (Direct) |
View |
| 2024-10-30 Sale |
2024-11-01 8:59 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,000 | $32.6 | $651,960 | 173,205 (Direct) |
View |
| 2024-10-16 Sale |
2024-10-18 8:57 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
91,634 | $31.41 | $2,878,038 | 1,016,725 (Direct) |
View |
| 2024-10-14 Sale |
2024-10-16 8:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $30.15 | $1,206,080 | 327,002 (Indirect Direct) |
View |
| 2024-10-14 Sale |
2024-10-16 8:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,961 | $30.37 | $636,490 | 114,897 (Direct) |
View |
| 2024-10-01 Sale |
2024-10-03 8:09 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.18 | $281,770 | 286,286 (Indirect Direct) |
View |
| 2024-09-20 Sale |
2024-09-23 6:00 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,500 | $27.65 | $152,086 | 103,253 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-18 9:19 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
8,393 | $27.54 | $231,175 | 185,450 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:16 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
568 | $26.18 | $14,870 | 296,286 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:14 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
637 | $26.18 | $16,677 | 75,294 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:13 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
639 | $26.18 | $16,729 | 41,152 (Direct) |
View |
| 2024-09-10 Sale |
2024-09-13 5:11 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
537 | $26.18 | $14,059 | 180,705 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-27 Exercise |
2025-01-31 09:14 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
16,849 | $0.615 | 148,433 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-31 09:14 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
21,569 | $21.09 | 148,433 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-31 09:14 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
15,172 | $6.364 | 148,433 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-31 09:14 am |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
53,590 | $0 | 148,433 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-31 09:14 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
49,074 | $21.1 | 149,069 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-31 09:14 am |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
49,074 | $0 | 149,069 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
16,264 | $21.1 | 356,424 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A 2033-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
31,250 | $0 | 356,424 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
14,986 | $19.87 | 356,424 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $0 | 112,674 (Direct) |
View |
| 2025-01-27 Exercise |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
4,000 | $19.87 | 112,674 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-29 8:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
234 | $19.69 | 112,674 (Direct) |
View |
| 2025-01-24 Exercise |
2025-01-27 6:08 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
43,064 | $6.364 | 321,147 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 6:08 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
43,064 | $0 | 321,147 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 6:07 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
50,000 | $0.615 | 798,274 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 6:07 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
50,000 | $0 | 798,274 (Direct) |
View |
| 2025-01-07 Gift |
2025-01-10 7:38 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
14,000 | $0 | 170,237 (Direct) |
View |
| 2024-12-26 Gift |
2024-12-30 8:20 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
14,100 | $0 | 184,237 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 9:08 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
98,000 | $0 | 361,783 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 9:03 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy |
69,500 | $0 | 86,358 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 9:01 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,074 | $21.1 | 189,348 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 9:01 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,074 | $0 | 189,348 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 9:01 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
98,000 | $0 | 189,348 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 8:59 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
98,000 | $0 | 136,335 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 8:56 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Gangloff Scott A. Chief Technology Officer |
98,000 | $0 | 98,000 (Direct) |
View |
| 2024-12-17 Exercise |
2024-12-18 8:52 pm |
N/A 2033-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
3,800 | $0 | 393,292 (Direct) |
View |
| 2024-12-17 Exercise |
2024-12-18 8:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
3,800 | $19.87 | 393,292 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 8:52 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
80,000 | $0 | 393,292 (Direct) |
View |
| 2024-12-16 Option Award |
2024-12-18 8:50 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
394,100 | $0 | 991,662 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 8:44 pm |
N/A 2033-12-08 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,450 | $0 | 317,092 (Direct) |
View |
| 2024-12-10 Exercise |
2024-12-12 8:44 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
2,450 | $19.87 | 317,092 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 7:36 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $21.1 | 716,446 (Direct) |
View |
| 2024-12-02 Exercise |
2024-12-04 7:36 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 716,446 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 9:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,061 | $21.1 | 127,579 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 9:57 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
9,061 | $0 | 127,579 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 5:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0.615 | 91,007 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 5:06 pm |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $0 | 91,007 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:04 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,716 | $21.09 | 276,286 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:04 am |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,716 | $0 | 276,286 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:00 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
108,366 | $21.1 | 904,561 (Direct) |
View |
| 2024-11-01 Exercise |
2024-11-05 09:00 am |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
108,366 | $0 | 904,561 (Direct) |
View |
| 2024-10-30 Exercise |
2024-11-01 8:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,000 | $21.1 | 173,205 (Direct) |
View |
| 2024-10-30 Exercise |
2024-11-01 8:59 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
20,000 | $0 | 173,205 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-18 8:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
91,634 | $21.1 | 1,016,725 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-18 8:57 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
91,634 | $0 | 1,016,725 (Direct) |
View |
| 2024-10-14 Exercise |
2024-10-16 8:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $21.09 | 327,002 (Direct) |
View |
| 2024-10-14 Exercise |
2024-10-16 8:06 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $0 | 327,002 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 8:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
19,825 | $0.615 | 114,897 (Direct) |
View |
| 2024-10-15 Exercise |
2024-10-16 8:06 pm |
N/A 2028-09-26 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
19,825 | $0 | 114,897 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-23 6:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,500 | $0.615 | 103,253 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-23 6:00 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,500 | $0 | 103,253 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 9:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
8,393 | $0.615 | 185,450 (Direct) |
View |
| 2024-09-16 Exercise |
2024-09-18 9:19 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
8,393 | $0 | 185,450 (Direct) |
View |